Keyword Connections

meropenem

Journals

4

1 Bioorganic & medicinal chemistry letters

2 Inorganic chemistry

3 Antimicrobial resistance and infection control

4 georgian medical news

Research Groups

0

No Research Group Connected

Bibliographies

23

1 Cost-effectiveness analysis comparing ceftazidime/avibactam (CAZ-AVI) as empirical treatment comparing to ceftolozane/tazobactam and to meropenem for complicated intra-abdominal infection (cIAI).

2 [PROBLEM OF ENSURING THE RIGHT TO MEDICAL CARE OF A DETAINEE (DETAINED IN CUSTODY) WITHIN CRIMINAL PROCEEDINGS: EXPERIENCE OF UKRAINE AND FOREIGN COUNTRIES].

3 Dithiocarbamates: Efficient metallo-β-lactamase inhibitors with good antibacterial activity when combined with meropenem.

4 Coordination Chemistry and QTAIM Analysis of Homoleptic Dithiocarbamate Complexes, M(SCNPr) (M = Ti, Zr, Hf, Th, U, Np).

5 meropenem – therapeutic recommendation after twenty years of presence on pharmaceutical market

6 metallo-β-lactamase-production in meropenem-susceptible pseudomonas aeruginosa isolates: risk for silent spread

7 Effects of sub-inhibitory concentrations of meropenem and tigecycline on the expression of genes regulating pili, efflux pumps and virulence factors involved in biofilm formation by Acinetobacter baumannii

8 Overview of meropenem-vaborbactam and newer antimicrobial agents for the treatment of carbapenem-resistant Enterobacteriaceae

9 Synergy effect of meropenem-based combinations against Acinetobacter baumannii: a systematic review and meta-analysis

10 Effects of sub-inhibitory concentrations of meropenem and tigecycline on the expression of genes regulating pili, efflux pumps and virulence factors involved in biofilm formation by Acinetobacter baumannii

11 Overview of meropenem-vaborbactam and newer antimicrobial agents for the treatment of carbapenem-resistant Enterobacteriaceae

12 Synergy effect of meropenem-based combinations against Acinetobacter baumannii: a systematic review and meta-analysis

13 Successful Clearance of Persistent Methicillin-Resistant Bacteremia with Daptomycin, Linezolid, and Meropenem Salvage Therapy.

14 Spectral signal processing approaches for selective quantification of the recently FDA approved brand-new combination of Vaborbactam and Meropenem; for conformity assessment of bulk and batch release

15 transfer of meropenem in the ex vivo human placenta perfusion model

16 resistensi <em>klebsiella</em> sp terhadap meropenem di rsud prof. dr. margono soekarjo purwokerto

17 Performance of the EUCAST disc diffusion method and two MIC methods in detection of Enterobacteriaceae with reduced susceptibility to meropenem: the NordicAST CPE study

18 Fluoroquinolone Prophylaxis Selects for Meropenem-nonsusceptible Pseudomonas aeruginosa in Patients With Hematologic Malignancies and Hematopoietic Cell Transplant Recipients

19 Morphological changes induced by imipenem and meropenem at sub-inhibitory concentrations in Acinetobacter baumannii

20 resistensi klebsiella sp terhadap meropenem di rsud prof. dr. margono soekarjo purwokerto

21 Optimization of antibiotics for cystic fibrosis pulmonary exacerbations due to highly resistant nonlactose fermenting Gram negative bacilli: Meropenem-vaborbactam and cefiderocol

22 Individual meropenem epithelial lining fluid and plasma PK/PD target attainment.

23 Individual target pharmacokinetic/pharmacodynamic attainment rates among meropenem-treated patients admitted to the ICU with hospital-acquired pneumonia.